AlphAIalphai — Financial news for AI agents
simplywall.stAUG 262 min read$ARES

Ares Management (ARES) Could Be 2% Undervalued On Q2 Results And MedImpact Loan

Ares Management (ARES) reported Q2 results and secured a $2.2b loan for MedImpact. The stock is at $142.76, with mixed yearly returns but strong long-term performance. Analysts estimate a fair value of $145.24, suggesting a slight undervaluation, though the P/E ratio is high compared to peers.

Original reporting
simplywall.st
Published Aug 26, 2026, 7:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Ares Management (ARES) Could Be 2% Undervalued On Q2 Results And MedImpact Loan — source image
Source · simplywall.st
Decision brief

The 30-second read

$ARESBullishMed
01

Why it matters

The loan could improve fee revenue and earnings visibility, but valuation concerns remain.

02

Market read

New loan adds fee‑earning potential for Ares; investors may reassess valuation.

03

What to watch

Potential credit risk of MedImpact and execution challenges.

Relevance 6/10Novelty 6/10Timing: post‑Q2 release, loan announced July 31

Background

Ares Management's Q2 results showed mixed performance, and the new loan is positioned as a growth catalyst.

Company-level read

Ticker impact

$ARESBullishMedium confidence
Context

Ares Management announced a new $2.2 billion direct loan for MedImpact Holding following its Q2 earnings release.

Expected impact

Potential modest upside as investors price in higher fee revenue.

Evidence & confidence

Large loan adds fee income; market may react positively if execution proceeds as expected.

Market effects

Sector

Highlights continued demand for private credit and could benefit peers in the asset‑management sector.

Regional

U.S. private credit market sees increased capital deployment.

Global

Adds to global liquidity in direct lending, modest impact.

Counterpoint

What could challenge this read

High valuation multiples may limit upside despite the loan.

Key entities

  • Company
    Ares Management

    Asset manager issuing the loan.

  • Company
    MedImpact Holding

    Borrower of the $2.2 billion loan.

Read at source← All news

Related articles

AUG 26
$ARESHighAI 8/10

Ares Management Stock: Analyst Estimates & Ratings

Ares Management (ARES) underperformed the S&P 500 and XLF ETF over the past year, with a 20.8% decline. Q2 revenue missed estimates at $1.26B, while EPS met expectations at $1.29. Analysts have a 'Moderate Buy' consensus, with a mean price target of $150.80, suggesting a 6.8% upside.

yahoo.com2 min
AUG 8
$ARESMed

Everton & other writings by Paul Quinn, The Analysis Series, Talking the Blues & the esk PodcastsThe Analysis Series: Ares Management Corporation, corporate update and sports exposure

Ares Management (NYSE: ARES) reports Q2 2026 results with record gross fundraising of about $36bn, AUM about $671bn, fee-paying AUM about $410bn, and fee-related earnings of $491.1m, and raises its quarterly dividend to $1.35. The article cites stock down about 32% over 52 weeks and ASIF redemptions exceeding a 5% cap. It also discusses ARCC non-accruals rising and football-related credit losses tied to Eagle Football and Chelsea exposure.

theesk.org12 min
AUG 4
$ARESMedAI 8/10

Ares (ARES) Q2 2026 Earnings Call Transcript

Ares Management (ARES) reported Q2 2026 results on an earnings call. Total AUM was about $671B, up 17% year over year, with gross fundraising of $36B. Fee-related earnings were about $491M (+20%), realized income about $522M (+31%), and after-tax realized income $1.29 per share (+25%). The company declared a $1.35 dividend per share.

fool.com6 min
AUG 3
$ARESMed

Why is Ares Management stock surging today?

Ares Management shares rose 5.3% to $134.92 after its Q2 2026 results. The company reported revenue of $1.43B vs. $1.33B expected, after-tax realized income per share of $1.29 (+25% YoY), and record $36.4B gross fundraising, lifting AUM 17% to $671.3B. Analysts raised price targets following the beat.

investing.com3 min